| 注册
首页|期刊导航|中国伤残医学|瑞替普酶联用参附注射液治疗120例AMI合并心力衰竭的临床疗效评价

瑞替普酶联用参附注射液治疗120例AMI合并心力衰竭的临床疗效评价

于淑慧

中国伤残医学Issue(8):26-27,2.
中国伤残医学Issue(8):26-27,2.DOI:10.13214/j.cnki.cjotadm.2015.08.016

瑞替普酶联用参附注射液治疗120例AMI合并心力衰竭的临床疗效评价

Clinicla efficacy of reteplase combined with Shenfu Injection for AMI complicated with heartfailure(120 cases)

于淑慧1

作者信息

  • 1. 辽宁省凤城市中心医院,辽宁凤城 118100
  • 折叠

摘要

Abstract

Objective:To investigate the clinical effect of reteplase combined with Shenfu Injection for acute myocardial infarction com-plicated with heart failure.Methods:From 2010 January~2014 March,203 cases with acute myocardial infarction complicated with heart failure in our hospital were selected as the research object, and were randomly divided into 2 groups, 83 cases in the control group were trea-ted with reteplase, the observation group(120 cases) were treated with reteplase combined with Shenfu injection treatment.Then the two groups of patients with recanalization time and recanalization rate before and after treatment, and postoperative complication incidence of car-diac troponin T were analyzed and compared.Results:Two groups of patients with recanalization time and comparison, the recanalization rate of cardiac troponin levels after treatment in seventh days 1 and fifteenth days after treatment, P<0.05, there was significant difference in incidence of complications, first day and cardiac troponin levels before treatment, after treatment, P>0.05, no statistical significance. Conclusion:Compared with reteplase only,the clinical curative effect of reteplase combined with Shenfu Injection in the treatment of acute myocardial infarction complicated with heart failure was better, and the security should be good, recommended in clinical application.

关键词

瑞替普酶/参附注射液/急性心肌梗死/心力衰竭/药物疗法

Key words

Reteplase/Shenfu injection/Acute myocardial infarction/heart failure/Drug therapy

分类

医药卫生

引用本文复制引用

于淑慧..瑞替普酶联用参附注射液治疗120例AMI合并心力衰竭的临床疗效评价[J].中国伤残医学,2015,(8):26-27,2.

中国伤残医学

1673-6567

访问量2
|
下载量0
段落导航相关论文